CRISPR Therapeutics AG

CRSP

$122.34

+39.1% (1 year change)

Market Cap

$9.02 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$76.71 - $220.20

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

-22.98x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $9.02 Billion
Enterprise Value $7.21 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return +39.1%
52-Week High $220.20
52-Week Low $76.71
Beta 1.41
Outstanding Shares 75.8 Million
Avg 30 Day Volume 1.2 Million

Valuation

P/E Ratio -22.98
PEG -36.9
Earnings per Share -$5.65
Price to Sales Ratio Infinity
Price to Book Ratio 5.32
Revenue to Enterprise Value 6548.87
EBIT to Enterprise Value -18.24
Total Debt to Enterprise Value 0.0
Debt to Equity 0.0

Profitability

Revenue $1.1 Million
Gross Profit $1.1 Million
EBIT -$395 Million
Net Income -$392 Million
Profit Margin -35630.97%
Quarterly Earnings Growth (YoY) +62.3%
Return on Equity -21.73%
Return on Assets -20.04%
Return on Invested Capital -21.09%

News

CRSP Stock: The Good News Goosing CRISPR Therapeutics Shares Today

CRSP Stock: The Good News Goosing CRISPR Therapeutics Shares Today

Shares of CRSP stock are rising on Friday after CRISPR Therapeutics provided a positive business update regarding its leading drug candidate.

InvestorPlace InvestorPlace, 4 days ago
CRISPR Therapeutics EPS beats by $5.59, beats on revenue

CRISPR Therapeutics EPS beats by $5.59, beats on revenue

No summary available.

Seeking Alpha Seeking Alpha, 5 days ago
Traynor Capital Management, Inc. Buys DoorDash Inc, Airbnb Inc, CRISPR Therapeutics AG, Sells ...

Traynor Capital Management, Inc. Buys DoorDash Inc, Airbnb Inc, CRISPR Therapeutics AG, Sells ...

Related Stocks: IJH , CRSP , BA , IJR , PLTR , DFEN , DASH , ABNB , FNCL , QDEL , ISRG , TLRY , ATOM , GME , BE , ARKK , NQP , CGC ,

GuruFocus GuruFocus, 13 days ago